Načítá se...
mTOR Inhibitors for Treatment of Low-Risk Prostate Cancer
Prostate cancer incidence increases with age; along with many other cancers, it could be considered a disease of aging. Prostate cancer screening has led to a significant proportion of men diagnosed with low-grade, low-stage prostate cancer who are now more likely to choose an active surveillance st...
Uloženo v:
| Vydáno v: | Med Hypotheses |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902872/ https://ncbi.nlm.nih.gov/pubmed/30077200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2018.06.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|